Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: Involvement of IFN-γ

International Immunology

Volumn 10, Issue 10, 1998, Pages 1441-1447

  Hsu, Shiou Chih ^a   Obeid, Obeid E ^a   Collins, Margaret ^b   Iqbal, Muhammed ^b   Chargelegue, Daniel ^a   Steward, Michael W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Measles virus; Minigene; Plasmid DNA; Respiratory syncytial virus; Signal sequences

Indexed keywords

DNA VACCINE; EPITOPE; GAMMA INTERFERON; PLASMID DNA; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; INTRADERMAL DRUG ADMINISTRATION; MEASLES VIRUS; MOUSE; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS LOAD;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; ENCEPHALITIS; EPITOPES; INTERFERON TYPE II; MEASLES; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIROVIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 0031686133     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.10.1441     Document Type: Article

References (36)

1. Kast, W. M., Roux, L., Curren, J., Blom, H. J. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D. and Melief, C. J. M. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl Acad. Sci. USA 88:2283.
2. Mohamed, O., Manuguerra, J. C., Livaditis, N., et al. 1996. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J. Immunol. 157:3039.
3. Carbone, F. and Bevan, M. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169:603.
4. Deres, K., Schild, H., Wiesmuller, K.-H., Jung, G. and Rammensee, H.-G. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561.
5. Chin, J., Magoffin, R. L., Shearer, L. A., et al. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449.
6. Nader, P. R., Horwitz, M. S. and Rosseau, J. 1968. Atypical exanthem following exposure to natural measles: eleven cases in children previously inoculated with killed vaccine. J. Pediatr. 72:22.
7. Openshaw, P. J., Clarke, S. L. and Record, F. M. 1992. Pulmonary eosinophilic responses to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4:493.
8. Garenne, M., Leroy, E., Beau, J. and Sene, I. 1991. Child mortality after high-titre measles vaccines: prospective study. Lancet 338:903.
9. Ulmer, J. B., Donnelly, J. J., Parker, S. E., et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
10. Ciernik, F., Berzofsky, J. A. and Carbone, D. P. 1996. Induction of cytotoxic T lympnocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 156:2369.
11. Kulkarni, A. B., Collins, P. L., Bacik, I., et al. 1995. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediator of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol. 69:1261.
12. k-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein Virology 72:2491.
13. Torres, C. A. T., Iwasaki, A., Barber, B. H. and Robinson, H. L. 1997. Differential dependence on target site tissue for gene gun intramuscular DNA immunisations. J. Immunol. 158:4529.
14. Roger-Zismann, B., Egan, J. E., Kress, Y. and Bloom, B. R. 1984. Isolation of cold-sensitive mutants of measles virus from persistently infected murine neuroblastoma cells. J. Virol. 51:845.
15. Taylor, G., Stott, E. J., Hughes, M. and Collins, A. P. 1984. Respiratory syncytial virus infection in mice. Infect. Immun. 43:649.
16. Obeid, O. E., Partidos, C. D., Howard, C. R. and Steward, M. W. 1995. Protection against morbilivirus-induced encephalitis by immunization with rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus. J. Virol. 69:1420.
17. Hall, C. B., Walsh, E. E., Long, C. E. and Schnabel, K. C. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163:693.
18. Restifo, N. P., Bacik, I., Irvine, K. R., Yewdell, J. W., McCabe, B. J., Anderson, R. W., Eisenlohr, L. C., Rosenberg, S. A. and Bennik, J. R. 1995. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154:4414.
19. Malin, A. S., Andersen, P., Content, J., Huygen, K. and Dockrell, H. M. 1996. Vaccinia expression of M. tuberculosis antigens is enhanced by a eukaryotic leader sequence. Immunology 89:66.
20. Kozak, M. 1984. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acid Res. 12:857.
21. Partidos, C. D., Vohra, P. and Steward, M. W. 1996. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides. Immunology 87:179.
22. Niewiesk, S., Brinckmann, U., Bankamp, B., Sirak, S., Liebert, U. G. and Ter Meulen, V. 1993. Susceptibility to measles virus induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes. J. Virol. 67:75.
23. Cannon, M. J., Stott, E. J., Taylor, G., et al. 1987. Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62:133.
24. Cannon, M. J., Openshaw, P. J. and Askonas, B. A. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163.
25. Kündig T. M., Hengartner, H. and Zingernagel, R. M. 1993. T cell dependent interferon gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J. Immunol. 150:2316.
26. York, I. A. and Rock, K. L. 1996. Antigen processing and presentation by class-I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
27. Morris, A. G., Lin, Y. L. and Askonas, B. A. 1982, Immune Interferon release when a cloned cytotoxic T-cell lines meets its correct influenza-infected target cells. Nature 295:150.
28. + lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice. J. Virol. 67:1044.
29. + T-cell memory determined by clonal burst size. Nature 369:652.
30. Zingernagel, R. M. 1990. Antiviral T-cell memory? Curr. Top. Microbiol. Immunol. 159:1.
31. + cytotoxic lymphocytes. J. Exp. Med. 187:48
32. Klenerman P., Hengartner, H. and Zinkernagel, R. M. 1997. A non-retroviral RNA virus persists in DNA form. Nature 380:288
33. Raz, E., Carson, D. A., Parker S. E., et al. 1994. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl Acad. Sci. USA 91:9519.
34. Selin, L. K. and Welsh, R. M. 1997. Cytolytically active memory CTL present in LCM-virus immune mice after clearance of virus infection. J. Immunol. 158:5366
35. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186:421.
36. h2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27:3341.